Introduction
Transcatheter aortic valve implantation (TAVI) is now an accepted standard of care for patients with symptomatic severe aortic stenosis (AS) who are not candidates for surgery or have high surgical risk. Over the past decade, the combined effect of learning curve, improvement in transcatheter device technology, a better understanding of aortic root anatomy, together with careful patient selection have gradually resulted in an improved clinical outcome for patients undergoing TAVI 1 . However, aortic regurgitation (AR) remains a common phenomenon following TAVI. Experience in large multicentre studies and registries, including over 6,000 patients, revealed that the incidence of AR after TAVI ranged from 48 to 93% of patients, with comparable prevalence between selfand balloon-expandable prostheses (Table 1) [2] [3] [4] [5] [6] [7] [8] [9] [10] . Trace or mild paravalvular AR is a common finding in the majority of patients, whereas only 14-21% of patients may have at least moderate AR following TAVI (Table 1) [2] [3] [4] [5] [6] [7] [8] [9] [10] . The observed variation in AR after TAVI may be related to the use of different modalities to assess AR (angiography, transoesophageal [TEE] or transthoracic [TTE] echocardiography), the different timing of AR assessment after TAVI (immediately post deployment, before hospital discharge and at 30-day follow-up) and the lack of a standardised protocol to grade AR severity (qualitative versus semi-quantitative methods). Accurate assessment of AR after TAVI is clinically relevant since moderate and severe post-procedural AR have been associated with poor treatment response 11 , early in-hospital death 2 and mid-term mortality 3, 5, 8, 11 . In addition, a recent report has suggested that residual AR grade >1 may also be associated with reduced survival 12 . Conversely, serial evaluations have shown that the severity of AR tends to reduce over time 3, 13, 14 . Current recommendations to characterise and quantify the severity of AR post TAVI include the morphology and location of the regurgitant jet, as well as the percentage of the circumference of the prosthesis occupied by the regurgitant jet. The value of cardiac imaging to evaluate the mechanisms underlying AR after TAVI and to quantify its severity will be discussed in this review.
Mechanisms of AR after TAVI
AR following TAVI can be categorised according to the location of the AR jet in relation to the prosthesis: either paravalvular AR (PAR) (between the prosthesis and the native annulus), transvalvular AR (TAR) (within the prosthesis) or both, and is best appreciated using colour-flow Doppler echocardiography (Figure 1) .
PAR can be due to incomplete annular sealing of the transcatheter valve. With conventional aortic valve surgery the native aortic valve is removed and the prosthesis is sewn onto the decalcified annulus, but in TAVI the native calcified aortic leaflets are displaced to accommodate the newly implanted prosthesis. The presence of asymmetrical/bulky aortic valve calcification has been related to the presence of PAR (Figure 2 ) 10, [15] [16] [17] [18] . Exact localisation of calcium in the aortic root and valve may predict PAR after TAVI 19, 20 . Particularly, calcification of the commissures has been associated with PAR but calcification of the body or the edge of the aortic cusps did not increase the risk of PAR 20, 21 . Other phenomena related to PAR include prosthesis undersizing 18, 22, 23 , bicuspid valve (asymmetrical expansion) 24 , incorrect depth of implantation (too high or low implantation without apposition to annular tissue) and an increased angle of the left ventricular outflow tract (LVOT) to the ascending aorta 25 . Multidetector row computed tomography is a valuable preprocedural imaging technique providing accurate sizing of the aortic annulus, precise characterisation of aortic valve anatomy and aortic root dimensions, and localisation of calcifications in the landing zone ( Figure 2 ) 20, 22, 23 .
In contrast, TAR is less often observed and may arise from valvular obstruction (from stiff guidewire or pigtail catheter or an overhanging native leaflet resulting in improper leaflet closure) 26, 27 , valvular damage (during crimping process or overexpansion following post-dilatation) 26, 28 or prosthesis oversizing (suboptimal stent expansion or impaired leaflet mobility). Prompt recognition of TAR and its mechanism is crucial, so that appropriate interventions such as manipulation of catheter or implantation of a second prosthesis (valve-in-valve procedure) can be performed in a timely manner to ensure good clinical outcome.
Imaging and quantification AR after TAVI
Currently, AR after TAVI is largely assessed using angiography, echocardiography or both. Using supra-aortic angiography, the degree of postprocedural AR is determined qualitatively by visual estimation of the concentration of contrast medium (regurgitation volume) in the left ventricle (LV) and classified into four grades: absent (grade 0), trace or mild (grade 1), mild-to-moderate (grade 2), moderate-to-severe (grade 3) and severe (grade 4) 29 . Although this is a commonly used method of assessment during TAVI, it lacks accurate quantification and has limited sensitivity in differentiating PAR from TAR (Figure 3) . Moreover, this modality is not preferred for serial AR evaluation after TAVI.
The other widely used method for AR assessment is echocardiography, and TEE is frequently performed to help guide transcatheter valve deployment and to detect complications during TAVI 30 . In addition, it permits assessment of the position and function of the prosthesis, including determination of the presence/severity and mechanism of AR immediately after valve deployment. In the setting of TAVI, it is critical to distinguish PAR from TAR and to determine its severity rapidly so as to allow for manoeuvres such as re-ballooning, attempting maximal expansion of the prosthesis in the presence of significant PAR or deployment of a second valve in the presence of severe TAR. Using the standard long-and short-axis views of colour Doppler TEE, PAR and TAR can both be accurately detected. With the current three-dimensional matrix array TEE probes, simultaneous display of two orthogonal real-time images (biplane long-and short-axis views) with superimposed colour flow Doppler imaging allows further delineation and exact localisation of the PAR (Figure 4) . However, accurate quantification of PAR remains challenging as it frequently consists of multiple small jets, origins of which may be obscured by the prosthesis stent/frame. Current recommendations for AR assessment after TAVI are derived from native valvular regurgitation, using multi-parametric approaches (Table 2) 31, 32 . In the setting of TAVI, modifications are required as the grading for PAR differs from that of TAR, with emphasis on the "jet anatomy" classification. For example, the width of the proximal AR jet relative to the LVOT diameter is the suggested criterion for semi-quantitative assessment of TAR severity ( Figure 5 ). In contrast, as PAR is frequently eccentric and irregular in shape, the proportion of the circumference of the prosthesis covered by the AR jet provides semi-quantitative assessment of PAR severity. However, this approach does not take into considera- Localisation of the PAR based on the standard parasternal short-axis TTE view of the aortic prosthesis is possible. In addition to a direct measurement of the vena contracta 33 , 3-D TTE may provide a more accurate calculation of the total stroke volume (both the regurgitant and forward stroke volumes) by subtracting LV end-systolic from LV enddiastolic volumes 34 . In the absence of significant mitral regurgitation, this method may be highly accurate since it is independent of geometric assumptions and is not hampered by foreshortened views. Therefore, 3-D echocardiography may become the method of choice for assessing complicated AR such as that following TAVI, although it requires further validation before widespread implementation in clinical routine. The feasibility of magnetic resonance imaging (MRI) for quantification of AR post TAVI has been evaluated: particularly velocityencoded phase imaging permits measurement of blood flow velocity and volume across the valve and calculation of the regurgi- Experience of AR assessment after TAVI and when to measure
Figure 2. Panel A shows a calcified tricuspid aortic valve of a patient with bulky calcification mainly in the non-coronary (arrow) and right cusps, and extending to the base of the interventricular septum (arrow) on multidetector computed tomography (MDCT). Following TAVI with a balloon-expandable (SAPIEN XT) valve, a paravalvular leak was observed with colour-coded Doppler transoesophageal echocardiography (TEE) that coincided with the location of the bulky calcification at the commissure between the right and non-coronary cusps on MDCT. Panel B shows the deployed frame and the arrow indicates the gap at the level of the commissure between the non-coronary and right cusps. Panel C shows the colour-coded Doppler TEE in a transgastric view with the paravalvular leak in the location of the calcification at right to non-coronary commissure.
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Acute postprocedural evaluation of AR after TAVI is crucial since the presence of moderate and severe AR is associated with increased mortality at follow-up and several manoeuvres can be performed at the catheterisation laboratory/hybrid operating theatre to reduce the severity of AR. In addition, the presence of AR should be monitored during the days after TAVI since the regurgitation grade may change (Table 3) . For example, the properties of the self-expandable prosthesis may lead to a reduction in the grade of PAR at follow-up. In 126 patients undergoing TAVI with self-expandable prostheses, Buellesfeld et al reported a reduction in the prevalence of PAR of any grade from 41% at 30 days after TAVI to 37% at two-year follow-up 13 . Experience with the balloon-expandable prostheses has also shown a progressive reduction in the prevalence of AR after TAVI. In the PARTNER cohort A trial, AR improved in 31.5% of patients at two-year follow-up 14 . Conversely, in the FRANCE 2 registry with 3,195 patients, the prevalence of AR remained unchanged at one-year follow-up 3 . Anatomo-pathological analyses of explanted self-expandable prostheses have demonstrated neointimal coverage of the frame struts in contact with the aortic wall but not in areas of high velocity blood flow such as the coronary ostia 36 . This neointimal tissue may be beneficial in reducing the grade of PAR by closing the gaps between the prosthetic frame and the native annulus. However, it has been suggested that, in specific circumstances, this tissue proliferation may lead to more rapid structural valve deterioration. So far, structural valve deterioration is anecdotal 37, 38 and other complications such as stent fracture, deformation or valve migration have not been described.
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Conclusions
AR after TAVI has been associated with worse outcome and increased mortality at follow-up. Accurate assessment of AR during the procedure is crucial to decide whether additional manoeuvres such as re-ballooning or valve-in-valve are needed to reduce the AR grade. Supra-aortic angiography or echocardiography (particularly 3-D TEE) are the preferred imaging techniques to assess AR immediately after valve deployment. In addition, continued evaluation of AR at follow-up is recommended since the grade of AR may change over time. For follow-up assessment, transthoracic echocardiography, particularly 3-D TTE, is the preferred imaging technique. 
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